Alnylam Pharmaceuticals, Inc.
$ALNY
Public valuation for Alnylam Pharmaceuticals, Inc. (ALNY). Fair value, signal, and key metrics — no sign-in required.
Current Price
$301.03
Fairly Valued
Fair Value Estimate
$301
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $434.72
44% higher than current
Key Metrics
Market Cap
$40.2B
Forward P/E
31.2x
Operating Margin
23.0%
Revenue Growth
108.1%
PEG Ratio
1.11
Get free watchlist alerts
Join the waitlist for valuation updates on $ALNY and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.